University of Helsinki
Klefström lab
Oncogenic signaling pathways as therapeutic targets in breast cancer
Our laboratory studies oncogene and tumor suppressor induced cancer-specific cellular programs, which cause therapeutic vulnerabilities in breast cancer.
News
We are looking to hire an ambitious Postdoc in Translational Immuno-Oncology
https://klefstromlab.com/home/open-positions/
What is hot in cancer research? Follow the famous ChasingCancer Blog by Shishir Pant
Klefström lab on facebook
Vapise syöpä - IO tulee ja tappaa (sitten kun lääkkeitä on saatavilla).
laaketeollisuus-sv.sivuviidakko.fi/uutishuone/blogit/vapise-syopa-io-tulee-ja-tappaa-sitten-kun-l...
Toimiva tutkimusekosysteemi tuo uudet hoidot potilaalle nopeasti
Klefström Lab retreat in Tvärminne biological research station. Beware breast cancer, your days are numbered #cancer.
www.helsinki.fi/en/news/health-news/combination-treatment-including-diabetes-drug-and-immunothera...
Researchers in Finland have discovered a drug combination that collaborates with the cancer cells' own MYC oncoprotein, which in large quantities causes self-destruction of the cancer cells.When this combination is enhanced with immune system-boosting anti-PD-1 therapy, a more effective and long-las...